AICDF pushes NPPA to increase the range of the medicines under NLEM

  • News
  • July 15, 2017

New Delhi : Recent surveys and high demands of thyroxine sodium clearly states that in India there are number of patients suffering from different levels and types of thyroid disease. Indian government claiming that GST implementation will definitely reduce the prices of the essential drugs, but government covers only insulin, critical-care products for kidney ailments, cancer, as well as anti-retrovirals under National List of Essential Medicines (NLEM).

Government added thyroxine sodium’s 50 mcg and 100 mcg dosages in the list of NLEM. It used to treat hypothyroidism, a condition because of low levels of thyroid hormone. But, what about the other strengths of the composition like 12.5mcg, 25mcg etc… AICDF urges NPPA to bring all stock keeping units (SKUs) of thyroxine sodium under National List of Essential Medicines (NLEM) to reduce their prices as there are number of users in India.

The main concern is the prices of thyroxine sodium’s 50 mcg and 100 mcg dosages are under price control but the other strengths of the molecule like 12.5 mcg, 25 mcg, 62.5 mcg, 75 mcg, 88 mcg, 112 mcg, 125 mcg, and 150 mcg are out of NLEM, that leads higher prices than 50 mcg and 100 mcg dosages. So, AICDF urges NPPA to add all the SKUs of thyroxine under NLEM.

Abbott India manufactured 50 mcg and 100 mcg Thyronorm tablets costs Rs.95.55 and Rs.126 respectively with GST. And the prices of 12.5 mcg and 25 mcg tablets which are not under price control costs at Rs.134.40 and Rs.128.10 respectively.

With the implementation of 12 per cent GST, the prices of Thyronorm tablets containing 12.5 mcg, 25 mcg, 50 mcg of thyroxine sodium have increased to Rs.134.40, Rs.130.20 and Rs.97.43 respectively.

Joydeep Sarkar, General Secretary, AICDF said they write to NPPA to benefit consumers who prescribed different dosages of the thyroxine sodium drug and If certain dosages of the same drug has been kept out of the NLEM, it defies the very purpose of price control.

  • Related Posts

    • News
    • May 27, 2025
    • 219 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    • News
    • February 1, 2025
    • 330 views
    Union Budget 2025 pleased Healthcare Leaders except for a Letdown or two

    New Delhi: Healthcare leaders expressed overall satisfaction over Union Budget 2025 except for a letdown or two. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), though appreciated…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    Key supplier in alprazolam smuggling racket arrested in Uttar Pradesh

    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Cough Syrup Smuggling Ring Busted in Bihar’s Samastipur; Two Women Among Seven Arrested

    Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

    Counterfeit cholesterol drugs worth Rs 3 lakh seized in raids at Koti

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product